ZA86290B - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
ZA86290B
ZA86290B ZA86290A ZA86290A ZA86290B ZA 86290 B ZA86290 B ZA 86290B ZA 86290 A ZA86290 A ZA 86290A ZA 86290 A ZA86290 A ZA 86290A ZA 86290 B ZA86290 B ZA 86290B
Authority
ZA
South Africa
Prior art keywords
6alkyl
compounds
histamine
chemical compounds
hydrogen
Prior art date
Application number
ZA86290A
Other languages
English (en)
Inventor
Thomas Henry Brown
Peter Blurton
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA86290B publication Critical patent/ZA86290B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
ZA86290A 1985-01-22 1986-01-15 Chemical compounds ZA86290B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858501535A GB8501535D0 (en) 1985-01-22 1985-01-22 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA86290B true ZA86290B (en) 1986-08-27

Family

ID=10573205

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA86290A ZA86290B (en) 1985-01-22 1986-01-15 Chemical compounds

Country Status (12)

Country Link
US (2) US4663331A (pt)
EP (1) EP0189307B1 (pt)
JP (1) JPS61172864A (pt)
AT (1) ATE56001T1 (pt)
AU (1) AU5226986A (pt)
CA (1) CA1267140A (pt)
DE (1) DE3673659D1 (pt)
DK (1) DK26686A (pt)
GB (1) GB8501535D0 (pt)
GR (1) GR860119B (pt)
PT (1) PT81863B (pt)
ZA (1) ZA86290B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010043795A1 (en) * 1998-08-07 2001-11-22 Anthony Wood Video data recorder for recording predefined format shows
DE60326080D1 (en) * 2002-10-09 2009-03-19 Schering Corp Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
EP1694659B8 (en) * 2003-12-19 2008-10-08 Schering Corporation Thiadiazoles as cxc- and cc- chemokine receptor ligands
EP1697354B1 (en) * 2003-12-22 2013-08-07 Merck Sharp & Dohme Corp. Isothiazole dioxides as cxc- and cc- chemokine receptor ligands
EP1907399B1 (en) * 2005-06-29 2010-10-27 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
WO2007002764A2 (en) * 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI76795C (fi) * 1979-09-04 1988-12-12 Bristol Myers Co Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 3,4-disubstituerade 1,2,5-tiadiazol-1-oxider och -1,1-dioxider samt nya mellanprodukter.

Also Published As

Publication number Publication date
US4732980A (en) 1988-03-22
EP0189307A3 (en) 1987-04-08
GB8501535D0 (en) 1985-02-20
CA1267140A (en) 1990-03-27
PT81863A (en) 1986-02-01
EP0189307B1 (en) 1990-08-29
EP0189307A2 (en) 1986-07-30
JPS61172864A (ja) 1986-08-04
ATE56001T1 (de) 1990-09-15
GR860119B (en) 1986-05-19
AU5226986A (en) 1986-07-31
DE3673659D1 (de) 1990-10-04
US4663331A (en) 1987-05-05
DK26686D0 (da) 1986-01-20
DK26686A (da) 1986-07-23
PT81863B (en) 1987-11-10

Similar Documents

Publication Publication Date Title
DE69129998D1 (de) Pyrimidindionderivate, deren Herstellung und Verwendung
HU913082D0 (en) Method for producing compounds having fibrinogene receptor antagonistic effect and therapeutical preparatives containing such compounds
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
NO169347C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
EP0357030A3 (en) Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
ES547826A0 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
ZA86290B (en) Chemical compounds
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
ATE82854T1 (de) Knochengezielte inhibitoren der karbonischen anhydrase.
GB8401093D0 (en) Cephem compounds
ES8609286A1 (es) Un metodo para preparar un compuesto de morfolinol
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
DK527186A (da) Bronchodilaterende farmaceutisk praeparat
IE56020B1 (en) Dioxocyclobutene compounds
DE3661311D1 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
ATE24716T1 (de) Lenkotrien-antagonisten.
FR2558161B1 (fr) 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique
ES8401966A1 (es) Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas.
DE3660959D1 (de) Benz-trisubstituted 2-aminotetralins
ES8402287A1 (es) Procedimiento de obtencion de nuevas carboxamidoguanidinas.
DK84785A (da) Kinatsalte af antimalariaforbindelsen mefloquin
HUT58742A (en) Process for producing alpha-adrenerg-receptor antagonistic thieno-benzazepines and pharmaceutical compositions containing them